fertilizer
Commented by Mario Hose on March 16th, 2026 | 06:55 CET
The Commodities Bet for 2026: Why Desert Gold Ventures Could Outperform Barrick Mining and How K+S is Benefiting from the Iran War
In the spring of 2026, the gold market is in a phase of extreme volatility that sends shivers down the spines of traders. Following a spectacular all-time high of over USD 5,400 per troy ounce in January, gold is now trading sideways in a volatile range of roughly USD 5,000–5,200. Investors are watching intently the players who extract this precious metal from the earth. At the centre of this is the exciting question of whether "smaller companies" like Desert Gold Ventures will outpace the sluggish giant producers. While Barrick Mining struggles with an unprecedented cost spiral, Desert Gold Ventures is already poised in Mali for its first production. This picture is complemented by a strategic look at K+S, which is currently benefiting from the war in Iran, as 30% of fertilizers pass through the Strait of Hormuz. Who is betting on the right commodity stocks now and will profit from them in 2026?
Read
Commented by André Will-Laudien on March 12th, 2026 | 07:05 CET
Sector rotation favors biotech and life sciences! BASF, MustGrow, Novo Nordisk, and BioNTech in focus
Surprises are currently widespread. Former Agriculture Minister Cem Özdemir will now lead the state parliament in Baden-Württemberg. The Green Party won over 30% of the vote in a landslide victory, putting issues such as environmental protection, social affairs, and, from Mr. Özdemir's time as minister, the agricultural industry back in the spotlight. With a human-centered approach and a focus on healthy nutrition, this means that established agricultural companies are increasingly being forced to reconcile productivity with sustainability. In this environment, MustGrow Biologics is positioning itself as a strategic technology provider whose achievements have already been validated by leading market players. An expanded sector view also includes the life sciences industry with the protagonists BASF, Novo Nordisk, and BioNTech - an exciting mix.
Read
Commented by Armin Schulz on March 11th, 2026 | 07:20 CET
Three trends, one goal: How Bayer, MustGrow Biologics, and BASF are turning the agricultural revolution into a profit opportunity
Three trends are currently driving the global agricultural economy: skyrocketing fertilizer prices, regulatory pressure to preserve biodiversity, and the insatiable hunger of a growing population. As farmers navigate between existential fears and the pressure to go green, a billion-dollar transformation of industry is looming. Old chemistry is reaching its limits, while demand for biological alternatives and precision technologies is reaching an all-time high. Amid this tension between volatility and opportunity, the future of plant production is being reshaped. We take a look at how Bayer, MustGrow Biologics, and BASF are driving this transformation and could benefit from it.
Read
Commented by Mario Hose on March 2nd, 2026 | 08:00 CET
Feeding a Growing World: Bayer, K+S, and MustGrow Biologics! Mustard, as a biological innovation, is transforming the agriculture of tomorrow!
Global agriculture faces mounting structural pressure. More than 8 billion people live on Earth today, and every person needs food every day. But the fields where we can grow food are getting smaller. Traditional methods of agriculture are losing acceptance, as synthetic fertilizers and chemical crop protection agents face stricter environmental oversight worldwide. That is why companies such as MustGrow Biologics, Bayer, and K+S are becoming increasingly important. These companies are working on a new type of agriculture. They are attempting to strike a balance: they aim to ensure good harvests while also protecting nature. The smaller innovator, MustGrow Biologics, exemplifies the shift toward effective biological alternatives in modern agriculture.
Read
Commented by Fabian Lorenz on February 9th, 2026 | 07:30 CET
Bayer shares in the fast lane! Partner MustGrow Biologics facing revaluation!
For Bayer, things are currently going extremely well. The group is bringing its problem areas under control while reporting tangible progress in its pharmaceutical business. In the shadow of this, the company has secured the license for a new biologically safe product platform for fertilizers. Its partner in this venture is MustGrow Biologics. The company is on the verge of transitioning from research to commercialization, with management planning a market launch later this year. Production capacities are already being expanded in Asia. Against this backdrop, MustGrow shares appear poised for a revaluation - and the company is increasingly emerging as a potential takeover candidate.
Read
Commented by Armin Schulz on February 2nd, 2026 | 07:40 CET
BASF, MustGrow Biologics, and K+S Alliance: How to benefit from the megatrend of food security
Global food security is facing a historic stress test. Driven by population dynamics, climate extremes, and geopolitical upheavals, efficient food production is becoming the central task of the century. Investors who want to invest in this systemic transformation are positioning themselves at critical points in the value chain. Three key players, a chemical giant, a pioneer in biological solutions, and a specialist in soil health, show where the greatest opportunities lie. The strategies of BASF, MustGrow Biologics, and K+S provide the decisive blueprints for the future.
Read
Commented by Armin Schulz on November 26th, 2025 | 07:05 CET
Deutsche Bank, Globex Mining, K+S: How to combine financial strength, the commodities boom, and food security
In uncertain times, savvy investors focus on companies with strong fundamentals and clear prospects for the future. Instead of relying on artificial connections, it is worth taking a look at three specific players, each of which plays to its own strengths in volatile markets: a financial giant that needs to prove its robustness, an agile mining explorer with access to coveted commodities, and a fertilizer specialist that benefits from global food security. An analysis of the individual opportunities and risks of Deutsche Bank, Globex Mining, and K+S promises valuable insights.
Read
Commented by Armin Schulz on September 1st, 2025 | 07:10 CEST
The hidden opportunity: Why Commerzbank, Desert Gold, and K+S are now in focus
The stock markets resemble a minefield: geopolitical tensions, unpredictable interest rate policies, and protectionist trade measures create an explosive mixture. In this environment, making informed investment decisions is crucial for protecting and growing capital. While safe havens are booming, cyclical stocks are struggling with the uncertainties. Against this backdrop, it is worthwhile to take a closer look at the strategic positioning of Commerzbank, the potential of gold explorer Desert Gold, and the resilience of fertilizer specialist K+S.
Read
Commented by Nico Popp on June 23rd, 2025 | 07:00 CEST
This trillion-dollar disruption is also sustainable for your portfolio: Argo Living Soils, Beyond Meat, Heidelberg Materials
Investors have seen it before: ambitious plans and grand revolutions that ultimately come to nothing - at least from an investor's perspective. The best example is the vegan revolution led by Beyond Meat – the Company's share chart certainly leaves a bad taste for any investor. But does that mean investors should be particularly critical of major innovations? We explain which disruptions truly deliver sustainable returns. It is all about sustainable construction - and benefits for all parties involved.
Read
Commented by Nico Popp on June 5th, 2025 | 07:00 CEST
These ESG innovations really exist: Bayer, Deere & Company, Argo Living Soils
Sustainability is anything but boring: Companies such as Bayer and Deere & Company are scoring points with technological innovations that are more reminiscent of Elon Musk and SpaceX than specialists in seeds and agricultural machinery. The small Canadian agricultural company Argo Living Soils has even found a solution to completely revolutionize CO2-intensive processes in construction. We present the business models and take a look at the outlook for the three stocks.
Read